Regenerative Medical Technology Group Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-6.8M | $3.0M |
| FY2022 | — | $-12.0M | $1.6M |
| FY2023 | — | $-21.8M | $530.5K |
| FY2024 | — | $-27.4M | $1.2M |
| FY2025 | $4 | $-34.7M | $956.7K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-6.8M | $3.0M |
| FY2022 | — | $-12.0M | $1.6M |
| FY2023 | — | $-21.8M | $530.5K |
| FY2024 | — | $-27.4M | $1.2M |
| FY2025 | $4 | $-34.7M | $956.7K |